OSTEOAMP has been shown to be 73.7% less expensive per level than Infuse in one published study where 321 patients were evaluated in a TLIF/LLIF approach.2
Donor bone is sourced from AATB-certified tissue banks in the United States.
All tissues are screened for the standard panel of infectious viruses.
Manufacturing and sterilization processes have been validated to inactivate the HIV-1, Bovine Hepatitis Virus (BHV), Bovine Viral Diarrhea Virus (BVDV), Hepatitus A Virus (HAV) and Porcine Parvovirus (PPV).
Request More Information
To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.
Material Management Packet:
OSTEOAMP Material Management Packet
Bioventus Surgical. Tidwell JL, Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogeneic morphogenetic proteins. Data on file, Bioventus white paper; 2017.
Roh JS, Yeung CA, Field JS, McClellan RT. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. J Orthop Surg Res. 2013;8:49. doi:10.1186/1749-799X-8-49.
Field J, Yeung C, Roh J. Clinical evaluation of allogeneic growth factor in cervical spine fusion. J Spine 2014;3(158) doi:10.4172/2165-7939.1000158.